Drug
Vedolizumab
Vedolizumab: highest development phase Phase 3, developed by Takeda. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vedolizumab IV NCT05837897 | Phase 3 | Crohn's Disease |
| Vedolizumab IV NCT06100289 | Phase 3 | Ulcerative Colitis |
Latest
No recent events.
Follow Vedolizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.